Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCTX | AZN | AMGN | GILD | BMY |
| Company | Lineage Cell Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.6300 | 192.64 | 370.68 | 146.85 | 59.67 |
| High | 1.7100 | 193.65 | 372.98 | 148.22 | 60.07 |
| Low | 1.5950 | 189.43 | 365.93 | 144.20 | 58.75 |
| Latest | 1.6100 | 189.90 | 366.21 | 144.99 | 59.08 |
| Change | +0.0300 | -2.60 | -1.58 | -0.22 | +0.13 |
| % Change | +1.90% | -1.35% | -0.43% | -0.15% | +0.22% |
| Volume | 1,398,700 | 1,429,000 | 1,500,300 | 4,375,700 | 9,395,500 |
| 20-Day Average Volume | 1,164,600 | 2,012,695 | 2,516,140 | 6,598,125 | 12,293,064 |
| Previous Close | 1.5800 | 192.50 | 367.79 | 145.21 | 58.95 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7975 | 201.54 | 376.49 | 148.47 | 60.75 |
| 20-Day Raw Stochastic | 8.54% | 2.35% | 16.11% | 15.66% | 16.64% |
| 20-Day Relative Strength | 43.63 | 43.81 | 50.80 | 52.04 | 50.76 |
| Weighted Alpha | +118.14 | +26.42 | +23.90 | +36.31 | +11.52 |
| Today's Opinion | 8% Buy | 56% Buy | 88% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 8% Buy | 56% Buy | 88% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 56% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.97% since 03/06/26 | -2.22% since 03/06/26 | -0.90% since 03/06/26 | +0.74% since 03/06/26 | -2.01% since 03/06/26 |
| Low | 1.5750 on 03/12/26 | 189.35 on 03/09/26 | 365.93 on 03/13/26 | 143.49 on 03/09/26 | 58.32 on 03/12/26 |
| High | 1.8600 on 03/10/26 | 198.09 on 03/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 60.96 on 03/10/26 |
| 1-Month | |||||
| %Chg | -3.01% since 02/13/26 | -7.61% since 02/13/26 | -0.81% since 02/13/26 | -6.45% since 02/13/26 | -2.73% since 02/13/26 |
| Low | 1.5750 on 03/12/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 58.32 on 03/12/26 |
| High | 1.9850 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -3.01% since 12/12/25 | +5.70% since 12/12/25 | +15.25% since 12/12/25 | +20.42% since 12/12/25 | +12.73% since 12/12/25 |
| Low | 1.4500 on 02/02/26 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 1.9850 on 03/02/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +20.15% since 09/12/25 | +19.34% since 09/12/25 | +32.50% since 09/12/25 | +26.57% since 09/12/25 | +27.88% since 09/12/25 |
| Low | 1.2800 on 09/15/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 2.0900 on 11/03/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 401,032 | 294,517,408 | 197,412,080 | 179,993,632 | 120,314,888 |
| Shares Outstanding, K | 249,088 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 14,560,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -63,530,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 6,610,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 850,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.74 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/06/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/12/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | 0.080 on 12/15/03 | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.02 | 16.83 | 17.82 | 9.59 |